Valuation: Terumo Corporation

Market Cap 3,63100Cr 2.27TCr 2.07TCr 1.91TCr 1.72TCr 3.25TCr 2,13600Cr 3.37TCr 23TCr 9.1TCr 1,14600Cr 8.54TCr 8.35TCr P/E 2027 *
40.2x
P/E 2028 * 19.1x
Enterprise Value 3,70400Cr 2.32TCr 2.11TCr 1.95TCr 1.76TCr 3.32TCr 2,17900Cr 3.44TCr 23TCr 9.28TCr 1,16900Cr 8.71TCr 8.52TCr EV / Sales 2027 *
3x
EV / Sales 2028 * 2.75x
Free-Float
97.34%
Yield 2027 *
1.46%
Yield 2028 * 1.64%
1 day+1.91%
1 week-0.12%
Current month+4.30%
1 month+7.18%
3 months-4.27%
6 months+10.05%
Current year+10.48%
1 week 2,280
Extreme 2280
2,583.5
1 month 2,280
Extreme 2280
2,639.5
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,900
Extreme 1900
3,182
5 years 1,708
Extreme 1708
3,182
10 years 958.75
Extreme 958.75
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.91%-0.12%+4.39%+6.29% 2.27TCr
-0.99%-2.77%-17.72%+7.17% 19TCr
+0.02%+0.09%+7.31%+37.39% 13TCr
+0.35%-4.61%-14.22%+6.58% 12TCr
+1.18%-3.20%-42.14%+3.72% 9.33TCr
-0.58%+3.23%-1.38%+81.27% 6.81TCr
-0.72%+0.57%+12.14%-7.91% 5.9TCr
-0.51%-0.85%+1.55%+50.15% 5.52TCr
-0.45%-1.00%-2.68%+37.47% 4.86TCr
+1.27%+1.50%+0.71%-0.19% 3.56TCr
Average +0.15%-0.42%-5.20%+22.19% 8TCr
Weighted average by Cap. -0.09%-1.01%-8.97%+20.87%

Financials

2027 *2028 *
Net sales 1,23400Cr 772.98Cr 702.26Cr 648.85Cr 586.08Cr 1.11TCr 73TCr 1.14TCr 7.8TCr 3.09TCr 39TCr 2.9TCr 2.84TCr 1,32100Cr 827.37Cr 751.66Cr 694.5Cr 627.32Cr 1.18TCr 78TCr 1.23TCr 8.35TCr 3.31TCr 42TCr 3.1TCr 3.04TCr
Net income 10TCr 66Cr 60Cr 55Cr 50Cr 94Cr 6.18TCr 97Cr 663.87Cr 263.04Cr 3.31TCr 246.78Cr 241.56Cr 19TCr 118.8Cr 107.93Cr 100Cr 90Cr 169.99Cr 11TCr 175.97Cr 1.2TCr 475.17Cr 5.99TCr 445.79Cr 436.36Cr
Net Debt 7.38TCr 46Cr 42Cr 39Cr 35Cr 66Cr 4.34TCr 69Cr 467.02Cr 185.04Cr 2.33TCr 173.6Cr 169.93Cr -211.49Cr -1.33Cr -1.2Cr -1.11Cr -1Cr -1.9Cr -124.42Cr -1.96Cr -13Cr -5.3Cr -67Cr -4.97Cr -4.87Cr
Projected Income Statement - Annual - Terumo Corporation
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
17/26/17 JP¥2,508.00 +1.91% 73,79,300
16/26/16 JP¥2,461.00 +2.54% 67,47,300
13/26/13 JP¥2,400.00 -6.18% 1,35,88,700
12/26/12 JP¥2,558.00 +1.67% 45,68,100
11/26/11 JP¥2,516.00 +0.20% 50,38,700
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Terumo Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,461.00JPY
Average target price
2,970.00JPY
Spread / Average Target
+20.68%
  1. Stock Market
  2. Stocks
  3. 4543 Stock